|
JPS60235136A
(ja)
*
|
1984-05-09 |
1985-11-21 |
Kyodo Printing Co Ltd |
検版方法
|
|
US4709914A
(en)
*
|
1985-02-07 |
1987-12-01 |
Brandt, Inc. |
Electronic controller for dispensers and the like
|
|
GB8704269D0
(en)
*
|
1987-02-24 |
1987-04-01 |
Rue Systems De |
Monitoring system
|
|
JPH0614384B2
(ja)
*
|
1987-04-13 |
1994-02-23 |
ローレルバンクマシン株式会社 |
紙幣判別装置
|
|
US4958307A
(en)
*
|
1987-11-20 |
1990-09-18 |
Kabushiki Kaisha Toshiba |
Roll mark inspection apparatus
|
|
US4951223A
(en)
*
|
1989-03-28 |
1990-08-21 |
Langdon Wales R |
Web material inspection system
|
|
GB2284293B
(en)
*
|
1993-11-30 |
1998-06-03 |
Mars Inc |
Article classifying method and apparatus
|
|
US5807552A
(en)
*
|
1995-08-04 |
1998-09-15 |
Board Of Regents, The University Of Texas System |
Compositions for conferring immunogenicity to a substance and uses thereof
|
|
US6610838B1
(en)
|
1997-09-10 |
2003-08-26 |
Symbicom Aktiebolag |
P13 antigens from Borrelia
|
|
HK1044040A1
(zh)
*
|
1998-11-16 |
2002-10-04 |
德克萨斯州立大学董事会 |
Hiv-特异的t-细胞诱导
|
|
US7327889B1
(en)
*
|
1999-10-06 |
2008-02-05 |
Omron Corporation |
Image recognition apparatus
|
|
DK1259251T3
(da)
*
|
2000-02-21 |
2006-03-06 |
Pharmexa As |
Hidtil ukendt fremgangsmåde til nedregulering af amyloid
|
|
HRP20020721B1
(en)
*
|
2000-02-21 |
2012-04-30 |
H. Lundbeck A/S |
Novel method for down-regulation of amyloid
|
|
US7097837B2
(en)
*
|
2001-02-19 |
2006-08-29 |
Pharmexa A/S |
Synthetic vaccine agents
|
|
US8163289B2
(en)
*
|
2001-03-09 |
2012-04-24 |
Iterative Therapeutics, Inc. |
Methods and compositions involving polymeric immunoglobulin fusion proteins
|
|
JP4401075B2
(ja)
|
2001-03-09 |
2010-01-20 |
ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システム |
葉酸結合タンパク質の改変体による腫瘍免疫の誘導
|
|
EP1395605B8
(en)
|
2001-03-09 |
2014-12-17 |
Iterative Therapeutics, Inc. |
Polymeric immunoglobulin fusion proteins that target low-affinity fcgamma receptors
|
|
SE0102327D0
(sv)
|
2001-06-28 |
2001-06-28 |
Active Biotech Ab |
A novel engineered superantigen for human therapy
|
|
MY144532A
(en)
|
2001-08-20 |
2011-09-30 |
Lundbeck & Co As H |
Novel method for down-regulation of amyloid
|
|
KR20040009725A
(ko)
*
|
2002-07-25 |
2004-01-31 |
삼성전자주식회사 |
화상형성장치의 용지공급장치 및 그 제어방법
|
|
EP1572714A4
(en)
|
2002-12-20 |
2006-08-09 |
Univ Texas |
VMP-Similar Sequences of Pathogenic Borrelia Species and Stem
|
|
US6900449B2
(en)
*
|
2003-01-15 |
2005-05-31 |
Lexmark International Inc. |
Media type sensing method for an imaging apparatus
|
|
WO2005035556A2
(en)
*
|
2003-05-06 |
2005-04-21 |
Iguazu Biosciences Corp. |
Sars-coronavirus virus-like particles and methods of use
|
|
WO2004099244A2
(en)
|
2003-05-09 |
2004-11-18 |
Pharmexa A/S |
Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation
|
|
CA2526690C
(en)
|
2003-05-23 |
2014-01-14 |
Board Of Regents The University Of Texas System |
Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors
|
|
WO2005055925A2
(en)
|
2003-09-10 |
2005-06-23 |
Board Of Regents, The University Of Texas System |
14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types
|
|
US7205561B2
(en)
*
|
2004-03-29 |
2007-04-17 |
Lexmark International, Inc. |
Media sensor apparatus using a two component media sensor for media absence detection
|
|
US7627938B2
(en)
*
|
2004-10-15 |
2009-12-08 |
Board Of Regents, The Univeristy Of Texas System |
Tapered hollow metallic microneedle array assembly and method of making and using the same
|
|
EP2353651A3
(en)
|
2004-10-22 |
2011-09-07 |
Neurologix, Inc. |
Use of apoptosis inhibiting compounds in degenerative neurological disorders
|
|
US20060210590A1
(en)
|
2005-02-03 |
2006-09-21 |
Alk-Abello A/S |
Minor allergen control to increase safety of immunotherapy
|
|
BRPI0617057A2
(pt)
|
2005-08-30 |
2011-07-12 |
Univ Miami |
anticorpo isolado, toxina especìfica para receptor de fator de necrose tumoral 25 (tnfr25), método para ativar o receptor de fator de necrose tumoral 25 (tnfr25), método para inibir a sinalização do receptor de fator de necrose tumoral 25 (tnfr25) numa célula, vacina antitumoral, método para imunizar um paciente contra tumor, método para tratar cáncer num paciente, método para tratar e/ou prevenir inflamação intestinal, composição terapêutica para a facilitação de um transplante de órgão, método para transplantar um tecido de um doador para um hospedeiro, método para inibir a expressão clonal de uma população de células t cd8 cognatas, método para tratar e/ou prevenir inflamação pulmonar, antagonista de tnfr25 isolado, composição e vetor de expressão
|
|
EP1767545B1
(en)
|
2005-09-22 |
2009-11-11 |
Biocompatibles UK Limited |
GLP-1 (Glucagon-like peptide-1) fusion polypeptides with increased peptidase resistance
|
|
EP2368570A3
(en)
|
2006-01-18 |
2012-05-02 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
|
EP1854455B1
(en)
|
2006-05-10 |
2009-10-07 |
Biocompatibles UK Limited |
Spherical microcapsules comprising GLP-1 peptides, their production and use
|
|
EP2046376B1
(en)
|
2006-08-01 |
2018-08-01 |
The Scripps Research Institute |
Vaccines and methods for controlling adiposity
|
|
US8080645B2
(en)
*
|
2007-10-01 |
2011-12-20 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection/transport compositions and methods
|
|
US8652782B2
(en)
|
2006-09-12 |
2014-02-18 |
Longhorn Vaccines & Diagnostics, Llc |
Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
|
|
US8097419B2
(en)
|
2006-09-12 |
2012-01-17 |
Longhorn Vaccines & Diagnostics Llc |
Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
|
|
US9481912B2
(en)
|
2006-09-12 |
2016-11-01 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
|
|
DE102007039485A1
(de)
*
|
2007-08-21 |
2009-02-26 |
Manroland Ag |
Verfahren zum Betreiben einer Rollendruckmaschine
|
|
US11041215B2
(en)
|
2007-08-24 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
PCR ready compositions and methods for detecting and identifying nucleic acid sequences
|
|
US9683256B2
(en)
|
2007-10-01 |
2017-06-20 |
Longhorn Vaccines And Diagnostics, Llc |
Biological specimen collection and transport system
|
|
CA2697373C
(en)
|
2007-08-27 |
2019-05-21 |
Longhorn Vaccines & Diagnostics, Llc |
Immunogenic compositions and methods
|
|
US10004799B2
(en)
|
2007-08-27 |
2018-06-26 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
|
WO2009032978A2
(en)
*
|
2007-09-07 |
2009-03-12 |
The Regents Of The University Of Michigan |
Compositions and methods for diagnosing and treating urinary tract infections
|
|
EP2195466B1
(en)
|
2007-10-01 |
2012-10-10 |
Longhorn Vaccines & Diagnostics, LLC |
Method of storing biological specimens
|
|
US11041216B2
(en)
|
2007-10-01 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
|
|
US9138470B2
(en)
*
|
2007-11-02 |
2015-09-22 |
The Johns Hopkins University |
Multi-component L2 vaccine for prevention of human papilloma virus infection
|
|
AU2010222929B2
(en)
*
|
2008-07-16 |
2013-07-25 |
Baylor Research Institute |
Antigen presenting cell targeted anti-viral vaccines
|
|
EP3301116A1
(en)
|
2008-08-25 |
2018-04-04 |
Dana Farber Cancer Institute, Inc. |
Conserved influenza hemagglutinin epitope and antibodies thereto
|
|
EP2163243A1
(en)
|
2008-09-12 |
2010-03-17 |
Biocompatibles UK Limited |
Treatment of acute myocardial infarction (AMI) using encapsulated cells encoding and secreting GLP-1 peptides or analogs thereof
|
|
EP2341929B1
(en)
|
2008-10-06 |
2017-01-25 |
University Of Chicago |
Compositions and methods related to bacterial emp proteins
|
|
CN102448989B
(zh)
*
|
2009-03-10 |
2015-09-30 |
贝勒研究院 |
抗-cd40抗体及其用途
|
|
JP5883653B2
(ja)
|
2009-03-10 |
2016-03-15 |
ベイラー リサーチ インスティテュートBaylor Research Institute |
抗原提示細胞ターゲティング抗ウイルスワクチン
|
|
HUE026855T2
(en)
|
2009-04-03 |
2016-07-28 |
Univ Chicago |
Compositions and methods related to protein a (spa) variants
|
|
EP2251028A1
(en)
|
2009-05-12 |
2010-11-17 |
Biocompatibles Uk Ltd. |
Treatment of eye diseases using encapsulated cells encoding and secreting an anti-angiogenic factor and/or a neuroprotective factor
|
|
EA022788B1
(ru)
|
2009-07-03 |
2016-03-31 |
Бионор Иммуно Ас |
Новые терапевтические и диагностические средства
|
|
WO2011063264A1
(en)
|
2009-11-20 |
2011-05-26 |
University Of Chicago |
Methods and compositions related to immunogenic fibrils
|
|
US9849174B2
(en)
|
2009-11-20 |
2017-12-26 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions related to immunogenic fibrils
|
|
GB0922209D0
(en)
|
2009-12-18 |
2010-02-03 |
Univ Nottingham |
Proteins, nucleic acid molecules and compositions
|
|
US9044606B2
(en)
|
2010-01-22 |
2015-06-02 |
Ethicon Endo-Surgery, Inc. |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
US8476227B2
(en)
|
2010-01-22 |
2013-07-02 |
Ethicon Endo-Surgery, Inc. |
Methods of activating a melanocortin-4 receptor pathway in obese subjects
|
|
US10080799B2
(en)
|
2010-02-12 |
2018-09-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
|
US20110229512A1
(en)
*
|
2010-03-19 |
2011-09-22 |
The Regents Of The University Of Michigan |
Compositions and methods for diagnosing and treating urinary tract infections
|
|
JP2013523818A
(ja)
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法
|
|
SG186290A1
(en)
|
2010-07-02 |
2013-01-30 |
Univ Chicago |
Compositions and methods related to protein a (spa) variants
|
|
US9095540B2
(en)
|
2010-09-09 |
2015-08-04 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
|
US20140004201A1
(en)
|
2010-09-15 |
2014-01-02 |
Biocompatibles Uk Ltd. |
Treatment of Vascular Diseases Using Encapsulated Cells Encoding and Secreting GLP-1, or a Fragment or Variant Thereof
|
|
WO2012092049A2
(en)
|
2010-12-29 |
2012-07-05 |
Ethicon Endo-Surgery, Inc. |
Brown adipocyte modification
|
|
TW201300418A
(zh)
|
2011-03-25 |
2013-01-01 |
Baylor Res Inst |
用於抗c型肝炎病毒免疫之組合物及方法
|
|
US9241983B2
(en)
|
2011-04-29 |
2016-01-26 |
Baylor College Of Medicine |
Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection
|
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
|
CA3207612A1
(en)
|
2012-01-26 |
2013-08-01 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
|
PL2844275T3
(pl)
|
2012-04-26 |
2021-03-08 |
University Of Chicago |
Koagulazy gronkowcowe stanowiące antygeny i sposoby ich zastosowania
|
|
HK1208150A1
(en)
|
2012-06-06 |
2016-02-26 |
Bionor Immuno As |
Vaccine
|
|
WO2015007337A1
(en)
|
2013-07-19 |
2015-01-22 |
Bionor Immuno As |
Method for the vaccination against hiv
|
|
JP7037884B2
(ja)
|
2014-01-13 |
2022-03-17 |
ベイラー リサーチ インスティテュート |
Hpv及びhpv関連疾患に対する新規のワクチン
|
|
US10214565B2
(en)
|
2014-03-10 |
2019-02-26 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for treating, including preventing, parvovirus infections and related diseases
|
|
CA2951616A1
(en)
|
2014-07-11 |
2016-01-14 |
Bionor Immuno As |
Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids)
|
|
US10092738B2
(en)
|
2014-12-29 |
2018-10-09 |
Ethicon Llc |
Methods and devices for inhibiting nerves when activating brown adipose tissue
|
|
US10080884B2
(en)
|
2014-12-29 |
2018-09-25 |
Ethicon Llc |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
CA2984991A1
(en)
|
2015-05-04 |
2016-11-10 |
Bionor Immuno As |
Dosage regimen for hiv vaccine
|
|
EP3294448A4
(en)
|
2015-05-14 |
2018-12-12 |
Longhorn Vaccines and Diagnostics, LLC |
Rapid methods for the extraction of nucleic acids from biological samples
|
|
US11246924B2
(en)
|
2016-04-01 |
2022-02-15 |
Duke University |
Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
|
|
US10610585B2
(en)
|
2017-09-26 |
2020-04-07 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and compositions for treating and preventing HIV
|
|
WO2019183500A1
(en)
|
2018-03-23 |
2019-09-26 |
Hung Chiung Yu |
Coccidioides antigens and methods of their use
|
|
US12514914B2
(en)
|
2019-05-14 |
2026-01-06 |
The University Of Chicago |
Methods and compositions comprising Staphylococcus protein a (SpA) variants
|
|
TW202327646A
(zh)
|
2021-10-15 |
2023-07-16 |
美商輝瑞大藥廠 |
Rna分子
|
|
AU2022410694A1
(en)
|
2021-12-17 |
2024-07-04 |
Pfizer Inc. |
Polynucleotide compositions and uses thereof
|
|
EP4469079A1
(en)
|
2022-01-28 |
2024-12-04 |
Pfizer Inc. |
Coronavirus antigen variants
|
|
IL320459A
(en)
|
2022-10-27 |
2025-06-01 |
Pfizer |
Rna molecules encoding rsv-f and vaccines containing them
|
|
EP4608441A1
(en)
|
2022-10-27 |
2025-09-03 |
Pfizer Inc. |
Immunogenic compositions against influenza and rsv
|
|
US20240252612A1
(en)
|
2022-12-11 |
2024-08-01 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
CN120813373A
(zh)
|
2023-01-16 |
2025-10-17 |
辉瑞大药厂 |
诱导针对水痘带状疱疹病毒的免疫反应的免疫原性组合物和方法
|
|
WO2024256962A1
(en)
|
2023-06-14 |
2024-12-19 |
Pfizer Inc. |
Method for stabilizing rna
|
|
WO2025027492A1
(en)
|
2023-07-31 |
2025-02-06 |
Pfizer Inc. |
Coronavirus antigen variants
|
|
WO2025126019A1
(en)
|
2023-12-13 |
2025-06-19 |
Pfizer Inc. |
Rna molecules
|
|
WO2025126071A1
(en)
|
2023-12-14 |
2025-06-19 |
Pfizer Inc. |
Rna molecules
|
|
WO2025186725A2
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Improved lnp formulations and uses thereof
|
|
WO2025186719A1
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
WO2025202834A1
(en)
|
2024-03-26 |
2025-10-02 |
Pfizer Inc. |
Polynucleotide compositions and uses thereof
|